Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by oilkidon Oct 11, 2007 10:13pm
269 Views
Post# 13559120

RE: Insider activity

RE: Insider activityHere is an email i got from TTH about insider trading. Seems just people selling some shares for xmas presents or vaction. Nothing really happening that we should worry Hello, Thank you for your email. To respond to your question regarding insider transactions. These transactions for most part occurred in early July or earlier. Each individual has earned options as part of their compensation and exercised those options for their own personal reasons. None of the insiders sold in anticipation of future news. The blackout policy of the company allows for a very narrow window of time for transactions with company stock. With this being the case, these transactions can be bunched together but this is most due to timing regarding the blackout policy. To my knowledge, there is no company material news that has not been released. If you wish to discuss further, feel free to contact me at the numbers below. Best regards, Carl Damiani Director of Business Development Transition Therapeutics Inc. New Phone Numbers Direct: (416) 263-1206 Tel: (416) 260-7770, ext. 206 Fax: (416) 260-2886 cdamiani@transitiontherapeutics.com
Bullboard Posts